Buy or sell PrognomiQ stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

PrognomiQ Stock

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

About PrognomiQ Stock

PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.

Funding History

September 2020$55.0M
March 2022$46.0M

Management

Interim CFO

David Siewers

Chief Executive Officer, President & Founder

Philip Ma

Co-Founder & Chairman

Omid Farokhzad

Board of Director

Tomer Berkovitz

Distinguished Scientist

John E. Blume

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo